Article

Tamoxifen shown to reduce gynecomastia in PCa patients

Tamoxifen (Nolvadex) reduces the frequency of gynecomastia and breast pain in prostate cancer patients taking bicalutamide (Casodex), according to a study in Lancet Oncology (2005; 6:295-300).

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Videos
Woman talking with doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
Yahir A. Santiago-Lastra, MD, answers a question during a Zoom video interview
Woman talking with a doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
Karyn S. Eilber, MD, answers a question during a Zoom video interview
Anna Myers, CNP, answers a question during a Zoom video interview
Drug costs | Image Credit: © pixelrobot - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.